By Helgi Library - April 2, 2020
Agrana Beteiligungs's total assets reached EUR 2,407 mil at the end of 2014, up 0.614% compared to the previous year. ...
By Helgi Library - April 2, 2020
Agrana Beteiligungs's total assets reached EUR 2,407 mil at the end of 2014, up 0.614% compared to the previous year. ...
Profit Statement |
Balance Sheet |
Ratios |
Valuation |
Get all company financials in excel:
Get all company financials in excel:
Agrana Beteiligungs AG is an Austria-based producer of fruit preparations for the dairy industry. The Company's products include fruit preparation, fruit base, sugar and starch products. The products of the Sugar Segment are marketed both directly to consumers through food retailers, and to the sugar-using industry. In the Starch segment, the Company processes and refines mainly corn (maize) and potatoes into starch products. The Fruit segment designs and produces fruit preparations (fruit ingredients) and fruit juice concentrates. The Company operates over 50 production sites on six continents. The Company also manufactures animal feed and fertilizers. Agrana has been listed on the Vienna Stock Exchange since 1991.
Agrana Beteiligungs has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 3.22% a year during that time to total of EUR 202 mil in 2014, or 8.09% of sales. That’s compared to 9.63% average margin seen in last five years.
The company netted EUR 80.9 mil in 2014 implying ROE of 6.78% and ROCE of 4.48%. Again, the average figures were 10.5% and 6.57%, respectively when looking at the previous 5 years.
Agrana Beteiligungs’s net debt amounted to EUR 507 mil at the end of 2014, or 0.425 of equity. When compared to EBITDA, net debt was 2.51x, up when compared to average of 2.19x seen in the last 5 years.
Agrana Beteiligungs stock traded at EUR 80.5 per share at the end of 2014 resulting in a market capitalization of USD 1,384 mil. Over the previous five years, stock price grew by 69.5% or 11.1% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 7.68x and price to earnings (PE) of 14.1x as of 2014.